Early cessation of triptorelin in in vitro fertilization: A double-blind, randomized study

This publication has 17 references indexed in Scilit:

• GnRH agonist versus antagonist therapy.
  Human Reproduction, 2002
• GnRH antagonist in assisted reproduction: a Cochrane review
  Human Reproduction, 2002
• Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation
  Human Reproduction, 2001
• Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation
  Fertility and Sterility, 2001
• Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial
  Human Reproduction, 2000
• Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization
  Fertility and Sterility, 1999
• Cessation of Gonadotropin-Releasing Hormone Agonist Therapy Combined with High-Dose Gonadotropin Stimulation Yields Favorable Pregnancy Results in Low Responders
  Fertility and Sterility, 1998
• Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program
  Fertility and Sterility, 1994
• Endocrinology: Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist
  Human Reproduction, 1993
• Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol
  Human Reproduction, 1992